Aerosolized vitamin a impact on lung maturation and hyperoxic neonatal lung injury
Ended Project Grant Awarded Last action
- Award ID
- R43HL142353
- Recipient
-
Advent Therapeutics Inc. UEI VMY3LNAJHQN9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $225,000 |
Quick answers
Who received award R43HL142353?
R43HL142353 was awarded to Advent Therapeutics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2018.
How much is award R43HL142353 worth?
$225,000 has been obligated on R43HL142353.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award